{
  "generated": "2026-02-10T12:00:00",
  "pipeline": "Genome Insight",
  "disclaimer": "NOT MEDICAL ADVICE",
  "total_findings": 8,
  "findings": [
    {
      "category": "Drug Metabolism",
      "variant": "rs762551",
      "genotype": "AC",
      "gene": "CYP1A2",
      "title": "CYP1A2 - Intermediate Caffeine Metabolizer",
      "description": "Intermediate caffeine metabolism",
      "tier": 2,
      "source": "CuratedSNP",
      "status": "intermediate",
      "magnitude": 2,
      "actions": [],
      "pathway_groups": ["Caffeine Response"]
    },
    {
      "category": "Neurotransmitters",
      "variant": "rs4680",
      "genotype": "AG",
      "gene": "COMT",
      "title": "COMT - Intermediate Dopamine Metabolism",
      "description": "Intermediate COMT activity",
      "tier": 2,
      "source": "CuratedSNP",
      "status": "intermediate",
      "magnitude": 2,
      "actions": [],
      "pathway_groups": ["Dopamine Metabolism"]
    },
    {
      "category": "Neurotransmitters",
      "variant": "rs6265",
      "genotype": "CT",
      "gene": "BDNF",
      "title": "BDNF - Reduced Neuroplasticity",
      "description": "Reduced BDNF secretion",
      "tier": 2,
      "source": "CuratedSNP",
      "status": "reduced",
      "magnitude": 2,
      "actions": [],
      "pathway_groups": ["Neuroplasticity"]
    },
    {
      "category": "Neurotransmitters",
      "variant": "rs25531",
      "genotype": "AG",
      "gene": "SLC6A4",
      "title": "SLC6A4 - Short Serotonin Transporter",
      "description": "Reduced serotonin transport",
      "tier": 2,
      "source": "CuratedSNP",
      "status": "short",
      "magnitude": 2,
      "actions": [],
      "pathway_groups": ["Serotonin"]
    },
    {
      "category": "Neurotransmitters",
      "variant": "rs1800497",
      "genotype": "CT",
      "gene": "ANKK1",
      "title": "ANKK1/DRD2 - Reduced Dopamine Receptors",
      "description": "Reduced D2 receptor density",
      "tier": 2,
      "source": "CuratedSNP",
      "status": "reduced",
      "magnitude": 2,
      "actions": [],
      "pathway_groups": ["Dopamine"]
    },
    {
      "category": "Neurotransmitters",
      "variant": "rs1799971",
      "genotype": "AG",
      "gene": "OPRM1",
      "title": "OPRM1 - Enhanced Opioid Response",
      "description": "Enhanced opioid receptor sensitivity",
      "tier": 2,
      "source": "CuratedSNP",
      "status": "enhanced",
      "magnitude": 2,
      "actions": [],
      "pathway_groups": ["Opioid"]
    },
    {
      "category": "Caffeine Response",
      "variant": "rs5751876",
      "genotype": "CT",
      "gene": "ADORA2A",
      "title": "ADORA2A - Moderate Adenosine Sensitivity",
      "description": "Moderate caffeine anxiety response",
      "tier": 1,
      "source": "CuratedSNP",
      "status": "moderate",
      "magnitude": 1,
      "actions": [],
      "pathway_groups": ["Caffeine Response"]
    },
    {
      "category": "Cardiovascular",
      "variant": "rs429358",
      "genotype": "CT",
      "gene": "APOE",
      "title": "APOE - E3/E4 Heterozygous",
      "description": "Moderately elevated Alzheimer risk",
      "tier": 3,
      "source": "CuratedSNP",
      "status": "e3_e4",
      "magnitude": 4,
      "actions": [],
      "pathway_groups": ["Lipid Metabolism"]
    }
  ]
}
